NCT00854750View on ClinicalTrials.gov

Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis

PHASE4TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

July 31, 2010

Conditions

Multiple Sclerosis

Interventions

DRUG

ACTHAR

SQ weekly injections

DRUG

ACTHAR

SQ weekly injections

DRUG

ACTHAR

SQ weekly injections

DRUG

ACTHAR

SQ weekly injection

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

Elliot Frohman

OTHER